Treating DVT
Dabigatran
Overview When the anticoagulant dabigatran (Pradaxa) was approved by the FDA in 2010 it was hailed as a "major milestone" in reducing the risk of strokes for patients with the irregular heart rhythm c…
Overview When the anticoagulant dabigatran (Pradaxa) was approved by the FDA in 2010 it was hailed as a "major milestone" in reducing the risk of strokes for patients with the irregular heart rhythm c…